tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Kymera Therapeutics Inc

KYMR
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
103.400USD
-3.610-3.37%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
8.51B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Kymera Therapeutics Inc

103.400
-3.610-3.37%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

KYMR ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Kymera Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Kymera Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Aug 5, 2026
EPS / ์˜ˆ์ƒ
--/-0.72
์ˆ˜์ต / ์˜ˆ์ƒ
--/30.44M
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
39.21M
-16.70%
EPS(YoY)
-3.69
-23.53%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
13.25%-0.71
-9.53%-0.97
-14.67%-0.94
-65.42%-0.95
-19.26%-0.82
-259.40%-0.88
9.29%-0.82
13.45%-0.58
2.46%-0.69
59.21%-0.25
---0.90
---0.67
---0.70
---0.60
---2.28
----
----
----
----
----
์ˆ˜์ต
55.50%34.37M
-61.18%2.87M
-26.12%2.76M
-55.26%11.48M
114.83%22.10M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
196.70%47.88M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
19.48%15.28M
39.93%20.34M
--18.52M
์ˆœ์ด์ต
-5.57%-69.23M
-22.94%-86.98M
-31.51%-82.17M
-82.15%-76.61M
-35.06%-65.58M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.80M
-11.57%-40.93M
-2.85%-34.87M
-50.45%-43.00M
-63.25%-40.26M
-180.57%-36.68M
-167.24%-33.90M
-257.90%-28.58M
---24.66M
์ˆœ์ด์ต๋ฅ 
32.11%-201.47%
-216.73%-3030.70%
-77.99%-2973.05%
-307.11%-667.60%
37.13%-296.75%
-3089.06%-956.88%
-49.38%-1670.33%
30.21%-163.98%
-9.17%-472.02%
86.11%-30.01%
---1118.17%
---234.96%
---432.37%
---216.03%
---390.86%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-54.74%0.17%
-50.88%0.19%
12.37%0.34%
55.23%0.36%
43.21%0.38%
-14.51%0.38%
-0.31%0.30%
-31.60%0.23%
-30.48%0.26%
1.76%0.45%
--0.30%
--0.34%
--0.38%
--0.44%
--0.28%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
55.50%34.37M
-61.18%2.87M
-26.12%2.76M
-55.26%11.48M
114.83%22.10M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
196.70%47.88M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
19.48%15.28M
39.93%20.34M
--18.52M
์˜์—… ์ด์ต
-13.07%-84.15M
-21.23%-97.90M
-22.94%-88.67M
-66.04%-84.56M
-40.68%-74.43M
-318.16%-80.75M
-25.41%-72.12M
-17.38%-50.92M
-16.72%-52.91M
50.01%-19.31M
-28.13%-57.51M
-6.30%-43.38M
-22.72%-45.33M
-13.64%-38.63M
-56.73%-44.88M
-65.02%-40.81M
-180.45%-36.93M
-165.95%-33.99M
-254.29%-28.64M
---24.73M
์ˆœ์ด์ต
-5.57%-69.23M
-22.94%-86.98M
-31.51%-82.17M
-82.15%-76.61M
-35.06%-65.58M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.80M
-11.57%-40.93M
-2.85%-34.87M
-50.45%-43.00M
-63.25%-40.26M
-180.57%-36.68M
-167.24%-33.90M
-257.90%-28.58M
---24.66M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
35.23%677.43M
70.74%871.21M
-7.11%528.30M
38.62%728.33M
-6.76%500.95M
25.89%510.27M
51.38%568.72M
36.33%525.41M
30.54%537.25M
-3.36%405.32M
-23.95%375.69M
-4.31%385.40M
-4.60%411.55M
-7.06%419.42M
-9.14%494.02M
10.41%402.77M
26.58%431.38M
49.26%451.27M
82.85%543.73M
130.45%364.81M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
6.19%62.64M
22.79%83.21M
7.58%71.58M
40.87%87.54M
5.08%58.99M
-20.92%67.77M
5.33%66.53M
13.81%62.14M
-9.36%56.14M
20.11%85.69M
-30.68%63.17M
-37.60%54.60M
-29.89%61.93M
-22.91%71.34M
-3.57%91.12M
-19.49%87.50M
-19.79%88.34M
-16.34%92.54M
-11.92%94.49M
154.65%108.69M
์ด ์ž์‚ฐ
81.75%1.67B
78.20%1.74B
6.49%1.10B
36.93%1.13B
5.77%918.31M
69.87%978.03M
87.34%1.03B
41.94%826.02M
41.43%868.25M
-4.54%575.76M
-13.48%552.38M
11.18%581.95M
9.03%613.90M
-0.46%603.13M
-0.62%638.47M
20.50%523.42M
21.20%563.06M
24.37%605.90M
26.63%642.45M
139.85%434.39M
๋ถ€์ฑ„ ์ด๊ณ„
-2.04%129.38M
14.56%163.15M
9.78%155.79M
13.11%159.59M
-15.90%132.08M
-21.22%142.42M
-9.52%141.91M
-3.70%141.10M
3.39%157.05M
60.01%180.79M
24.89%156.84M
16.77%146.52M
13.07%151.90M
-22.76%112.98M
-21.17%125.59M
-28.82%125.47M
-29.04%134.34M
-28.05%146.27M
-25.09%159.32M
128.74%176.28M
์ž๋ณธ ์ด๊ณ„
95.82%1.54B
89.04%1.58B
5.97%946.26M
41.84%971.48M
10.55%786.23M
111.56%835.62M
125.75%892.93M
57.30%684.92M
53.94%711.20M
-19.42%394.97M
-22.88%395.54M
9.42%435.43M
7.76%462.00M
6.64%490.15M
6.16%512.88M
54.18%397.95M
55.76%428.72M
61.91%459.64M
63.95%483.13M
148.07%258.10M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-12.24%-88.84M
-8.03%-66.75M
45.99%-27.11M
-39.47%-59.88M
-99.92%-79.15M
-867.98%-61.78M
-58.59%-50.19M
-21.78%-42.94M
9.95%-39.59M
120.35%8.04M
7.65%-31.65M
9.57%-35.26M
-9.12%-43.97M
-3.09%-39.54M
8.03%-34.27M
-27.77%-38.98M
-76.55%-40.30M
-91.11%-38.35M
-128.30%-37.26M
---30.51M
์ˆœํˆฌ์ž
-393.82%-142.84M
-675.19%-394.40M
-49.23%-235.30M
283.72%60.02M
114.70%48.62M
261.80%68.57M
-360.58%-157.68M
-56.35%15.64M
-1444.81%-330.61M
138.16%18.95M
261.44%60.51M
-56.19%35.84M
-4.95%24.58M
26.98%-49.67M
72.61%-37.48M
34.72%81.80M
-41.65%25.86M
-1604.74%-68.02M
59.06%-136.86M
--60.72M
์ˆœ์žฌ๋ฌดํ™œ๋™
7174.81%18.77M
25405.21%705.22M
-84.25%39.51M
17302.69%245.73M
-99.93%258.00K
42.97%2.77M
121904.85%250.92M
8.20%1.41M
30422.52%353.76M
-0.97%1.93M
-100.14%-206.00K
258.52%1.30M
526.49%1.16M
-4.92%1.95M
-38.83%150.50M
-77.14%364.00K
-68.91%185.00K
660.74%2.05M
25.35%246.04M
--1.59M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Kymera Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 39.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 47.07M์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 871.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 70.74์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 1.74B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 78.20์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 163.15M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 14.56์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 1.58B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 89.04์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -345.54M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.60์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -521.06M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -28.95์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kymera Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 990.71M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 62.72์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.69์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -23.53์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -311.35M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -39.08์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -794.04์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -66.97์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 0.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -50.88์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -25.78์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 29.14์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -22.89์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 20.57์ž…๋‹ˆ๋‹ค.

Kymera Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kymera Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -345.54M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.60์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ